Approval · Notice of Compliance 2111 · 2001
MONOCID: Notice of Compliance 2111
Issued August 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2111
- Date
- August 17, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MONOCID | 01970410 | — |
| MONOCID | 01970429 | — |
Medicinal ingredients
- CEFONICID SODIUM 500 MG per VIAL
- CEFONICID SODIUM 1 G per VIAL